Molecular cancer therapeutics.

ISSN 1535-7163American Association for Cancer Research Inc.United States
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Titles
Molecular Cancer Therapeutics
Mol. Cancer Ther. (abbreviated)
MOLECULAR CANCER THERAPEUTICS AMER ASSOC CANCER RESEARCH
Molecular cancer therapeutics.
Mol Cancer Ther (abbreviated)
ISSN
1535-7163
1535-7163
eISSN
1538-8514
NLM ID
101132535
Publisher
American Association for Cancer Research Inc.
Philadelphia, PA : American Association for Cancer Research, Inc., c2001-
Country
Language
English
ENG

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2001–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF20255.5Q11724JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
2.392
Best Quartile
Q1
H-index
212
Subject categories
  • Cancer Research — Q1
  • Oncology — Q1
More metrics
Coverage
2001–2026
Country
United States
Region
Northern America
Publisher
American Association for Cancer Research Inc.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
155
Total documents (3 years)
433
Total references
8459
Total citations (3 years)
2514
Citable documents (3 years)
425
Citations per document (2 years)
5.55
References per document
54.57
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1535-7163, 1538-8514
SCImago Source ID
12435
SCImago Rank (across all SCImago source types)
1046

Publication activity

Publication activity
2025
155 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Anticarcinogenic Agents; Antineoplastic Agents; Genetic Therapy; Neoplasms/prevention & controlNeoplasms/therapy; Pharmacogenetics
Scopus:2001-2026
MEDLINE:MEDLINE: v1n1,Nov. 2001-; PubMed: v1n1,Nov. 2001-; Index medicus
PubMed:MEDLINE: v1n1,Nov. 2001-; PubMed: v1n1,Nov. 2001-; Index medicus